China vs Norway: Cause of death, by non-communicable diseases, ages 15-59, female
China
82.6%
in 2021
Norway
83.0%
in 2021
China rank
18th
Norway rank
15th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- China
- Norway
How they compare
Norway currently reports 83.0% against 82.6% in China, a difference of 0.4%.
Across all 6 years both countries report, Norway has been ahead every year.
China ranks 18th and Norway ranks 15th of 185 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | China | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.1% | 85.1% | 11.0% | Norway |
| 2010s | 79.3% | 83.9% | 4.6% | Norway |
| 2020s | 82.0% | 83.6% | 1.5% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, China or Norway?
- Norway, at 83.0% against 82.6% in China as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between China and Norway?
- 0.4%, with Norway ahead.
- How many years of comparable data are there for China and Norway?
- 6 years are reported by both, from 2000 to 2021.
- How do China and Norway rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- China ranks 18th and Norway ranks 15th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.